Balyasny Asset Management LLC Wave Life Sciences Ltd. Transaction History

Balyasny Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$3.54 - $6.84 $217,458 - $420,174	-61,429 Reduced 69.04%	27,541 $169,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $218,890 - $361,485	52,618 Added 144.75%	88,970 $449,000
Q3 2023 Nov 14, 2023	BUY	$3.56 - $5.75 $129,413 - $209,024	36,352 New	36,352 $209,000
Q1 2023 May 15, 2023	BUY	$3.58 - $6.3 $69,341 - $122,024	19,369 Added 179.59%	30,154 $130,000
Q4 2022 Feb 14, 2023	BUY	$3.18 - $7.0 $34,296 - $75,495	10,785 New	10,785 $75,000
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.12 $1.91 Million - $2.78 Million	-390,104 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.65 - $7.47 $2.2 Million - $2.91 Million	390,104 New	390,104 $2.6 Million
Q1 2019 May 15, 2019	SELL	$32.69 - $47.91 $640,200 - $938,269	-19,584 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$37.1 - $50.11 $424,795 - $573,759	11,450 Added 140.77%	19,584 $823,000
Q3 2018 Nov 14, 2018	BUY	$36.35 - $55.2 $295,670 - $448,996	8,134 New	8,134 $407,000

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.17B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.